Wilson Sonsini Steers Tenaya Therapeutics To $92M Series B
Tenaya Therapeutics, which focuses on developing therapies targeting underlying causes of heart disease, said Thursday that it secured $92 million in financing commitments in its latest funding round, led by Wilson...To view the full article, register now.
Already a subscriber? Click here to view full article